Sarah Starling Crossan is a public affairs advisor in Holland & Knight's Washington, D.C., office and a member of the firm's Public Policy & Regulation Group. Ms. Crossan's practice focuses on regulatory and legislative healthcare policies, including physician payment, administrative burden and prior authorization, optimizing patient care coordination, social determinants of health (SDOH) metrics and value-based payment model development.
Prior to joining Holland & Knight, Ms. Crossan was an associate of regulatory affairs at the American College of Physicians (ACP). In this role, she led initiatives within value-based and physician payment/delivery systems, demonstrating proficiency in crafting comprehensive policy documents and fostering effective collaboration across multidisciplinary teams and government bodies. Before Ms. Crossan's most recent position, she served as professional staff on the Senate Committee on Health, Education, Labor, and Pension (HELP). In this capacity, she played a critical role in executing policy recommendations and facilitating congressional and agency collaboration. Additionally, her professional background extends to roles at a rare disease pharmaceutical company, where she worked in federal government affairs and regulatory affairs, obtaining a comprehensive understanding of legislative and regulatory drug pricing policies, U.S. Food and Drug Administration (FDA) regulatory compliance and clinical trial processes.
Ms. Crossan's dedication to advancing healthcare is substantiated by authored publications as the primary author, with notable works such as "Beyond the Discharge: Principles of Effective Care Transitions Between Settings" and "Beyond the Referral: Principles of Effective, Ongoing Primary and Specialty Care Collaboration."
In her past engagements, Ms. Crossan was a programmatic organizer for her prior company's culture team and was the lead staffer of the Council of Subspecialty Societies. Additionally, she previously served as a board member for Rare Together Tennessee, which is affiliated with the National Organization for Rare Disorders (NORD).
- Belmont University, B.S., Biology and Psychology; Neuroscience Studies